Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 31:14:123-130.
doi: 10.2147/PTT.S471707. eCollection 2024.

Metabolic Syndrome in Psoriasis and Psoriatic Arthritis in a Mixed Race Population: Comparison of Their Prevalences

Patrícia Medeiros Gusmão Acioly  1   2 , Mara Diane Lisboa Tavares Mazzillo  1   2 , Carla Jorge Machado  3 , Cláudia Camargo  2 , Maria Alice Penetra  2 , Virginia Januário  2 , Beatriz Ribeiro Dos Reis  1 , Marcia Ramos-E-Silva  1 , Sueli Carneiro  1   2
Affiliations

Metabolic Syndrome in Psoriasis and Psoriatic Arthritis in a Mixed Race Population: Comparison of Their Prevalences

Patrícia Medeiros Gusmão Acioly et al. Psoriasis (Auckl). .

Abstract

Background: There is a growing body of evidence suggesting the association between psoriasis (PsO) and psoriatic arthritis (PsA) separately with metabolic syndrome (MS) in different populations. The literature is relatively scarce in terms of comparing the prevalence of MS in PsO and PsA with controls without systemic inflammatory diseases.

Objective: We aimed to assess the prevalence of MS among patients with PsO, PsA, and a control group without systemic inflammatory disease, in addition to investigating the risks of MS occurrence and its different components in each group.

Methods: This is a cross-sectional case-control study with three groups of patients: PsO, PsA, and control. The diagnosis of MS was defined according to the modified 2009 NCTEP ATP III criteria. Patients underwent thorough physical examination and fasting blood samples.

Results: A total of 195 patients were included in this analysis (PsO = 50; PsA = 64, and controls = 81). The prevalence of MS in the control, PsO, and PsA groups was 37%, 56%, and 57.8%, respectively (p < 0.001). Waist circumference (p = 0.013) and arterial hypertension (p < 0.001) were the most significant components of MS in patients with PsO and PsA. Multivariate analysis confirmed an independent risk of MS in women, elderly patients, obese patients, patients with hyperglycemia, and patients with psoriasis, especially PsA (OR = 6.2 [CI 95% 2.4-16.2], p < 0.001).

Conclusion: MS is more prevalent in patients with PsA, which can be determined by the increase in inflammatory pathways.

Keywords: metabolic syndrome; obesity; prevalence; psoriasis; psoriatic arthritis.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest involved in the production of this manuscript.

References

    1. Duarte GV, Follador I, Cavalheiro CM, Silva TS, de Oliveira MF. Psoriasis and obesity: literature review and recommendations for management. An Bras Dermatol. 2010;85:355–360. doi:10.1590/S0365-05962010000300009 - DOI - PubMed
    1. Gisondi P, Girolomoni G. Psoriasis and atherothrombotic diseases: disease specific and non-disease-specific risk factors. Semin Thromb Hemost. 2009;35:313–324. doi:10.1055/s-0029-1222610 - DOI - PubMed
    1. Gottlieb A, Korman NJ, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol. 2008;58:851–864. doi:10.1016/j.jaad.2008.02.040 - DOI - PubMed
    1. Videira IFS, Marques AR, Neves ACP, Paiva DFP. Psoriasis and cardiovascular risk factors: observational study in an urban population of the North Region of Portugal. Rev Port Med Geral Fam. 2017;33:386–392.
    1. Ruiz DG, Azevedo MNL, Santos OLR. Psoriasic arthritis: a distinct clinical clinical entity from psoriasis? Rev Bras Reumatol. 2012;52:623–638. (Portuguese). - PubMed